Epstein Secrets

characteristics determined by AAUP --Laboratories. See Compliance statement A: aruplab.com/cS --mvw.aroPlab.com, Julio Delgado, MD - Lab. Director B. quintana Ab, IgG <1:64 --INTERPRETIVE INFORMATION: Bartonella quintana Antibody, IgG -- Less than 1:64 Negative: No significant level of Bartonella quint

ID: Address:9 EAST 71ST STREET, NEw YORK, NY 20021 This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulation

characteristics determined by AAUP --Laboratories. Se. Compliance statement A: aruplab.com/CS --44w.aroPlab.com, Julio Delgado, MD - Lab. Director B. quintana Ab, IgG <1:64 --INTERPRETIVE INFORMATION: Bartonella quintana Antibody, IgG -- Less than 1:64 Negative: No significant level of Bartonella quinta

ID: Address:9 EAST 7157 STREET, rev YORK, NY 20021 This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleaned or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulation

characteristics determined by ARUP --Laboratories. See Compliance Statement A: aruplab.com/CS --www.aruplab.com, Julio Delgado, MD - Lab. Director B. quintana Ab, Ig6 <1:64 --INTERPRETIVE INFORMATION: ilartonella quintana Antibody, IgG -- Less than 1:64 Negative: No significant level of Bartonella quint

08/30/2017 '08/30/aiii'l. • titer 1:64 g titer This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulation